Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Jura Provides Update on Dutch Attachment Proceedings
InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering
McFarlane Lake Mining Provides Update on Investor Relations and Marketing Service Engagements
Argo Corporation Announces Closing of Strategic Investment
